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A b s t r a c t  
Curcumin has poor aqueous solubility and has bioavailability problems. Hence in the present study 
the solubility of curcumin was increased by complexing with cyclodextrin (CD) and Hydroxy propyl β 
cyclodextrin(HPβCD). This complex is incorporated in to invasomes and then into HPMC gel to 
prepare as a transdermal formulation.Curcumin cyclodextrin complexes were prepared by physical 
mixture and co-precipitation method. Different formulations of invasomes containing 0.5, 1.0, 1.5 % 
of limonene, fenchone, nerolidol individually were prepared using mechanical dispersion technique. 
Invasomes were characterized for vesicular size, surface morphology, zeta potential, entrapment 
efficiency and percutaneous permeation.Formulations CHL1 and CHL2 were optimized for further 
studies. It was found in the study that complex with HPβCD in 1:2 proportion prepared by co-
precipitation method was found to bind 90% of curcumin.Invasomal preparation with 0.5% limonene, 
4% ethanol was found to enhance permeation by 8.11 times the control.In vivo diffusion studies 
were conducted using franz diffusion cell, ex vivo skin permeation studies of CHL1using rat 
abdominal skin showed cumulative drug permeated (Q24)of 70.32 øg/cm2, steady state transdermal 
flux of 3.344 øg/cm2/hr-1, permeability coefficient of 5.35 cm/hr and lag time of 1 hr when compared 
with control formulation. From the results it was concluded that the solubility of curcumin increased 
by complexing with HPβCD and invasomal preparation with 0.5% limonene has improved 
permeation through the skin. 
Keywords: đ- Curcumin, Cyclodextrin, Invasomes, HPMCK4M gel 
Introduction 
Curcumin known as diferuloylmethane a yellow polyphenol is an 
extract from rhizomes of Curcuma longa lin. This compound has 
potency against many diseases such as cough, diabetes, anorexia, 
alzheimer disease, rheumatism, hepatic disorders, antioxidant, 
anti-inflammatory, anti carcinogenic, hypocholesterolemic, 
antibacterial, antispasmodic, anticoagulant, anti tumor etc. 
[1].Although therapeutic properties of curcumin have been the topic 
of several studies widespread clinical applications of curcumin is 
limited due to its poor aqueous solubility, degradation at alkaline 
pH, photodegradation, low systemic bioavailability. Cyclodextrins 
are 1,4 đ linked cyclic oligosaccharides produced by enzymatic 
conversion of starch and contain atleast 6 D - (+) glucopyranose 
units. đ-CDÊsare insufficient in size for many drugs while γ-CDÊsare 
expensive. Usually β-CD has been used extensively for many 
studies because of its ready availability, cavity size and use with 
wide range of drugs. Cyclodextrins are used pharmaceutically for 
drug complexation, as solubilizers, diluents, bioavailability 
enhancers for poorly soluble drug [2]. Serum plasma levelswere 
found to be only 2.25øg/ml by intra peritoneal route and 0.36øg/ml 
by intravenous route [3, 4]. Curcumin was complexed with γ-
cyclodextrin using co-precipitation method to increase the 
solubility[5]. Anand et al., coated that nanoparticles, liposomes, 
phospholipid complexes are promising novel formulations which 
improve the bioavailability [6]. Transdermal route is the alternate 
pathway for localized or systemic pharmacological effects. 
Although advantageous in avoiding problems of poorly absorbable 
drugs and enzymatic degradation, penetration through the stratum 
corneum (SC) of epidermis an efficient barrier is the major 
problem. Hence several techniques and carrier systems were 
developed to cross this barrier.Liposomes,phospholipid vesicles 
are used as drug carriers. Traditional liposomes can be used only 
for topical application but they cannot deeply penetrate the skin 
and are restricted to upper layers of SC [7].Hence a series of 
vesicular carriers transferosomes® with edge activators, 
ethosomes with high amounts of ethanol, invasomes with ethanol 
and terpenes were developed. Elastic vesicles have shown to be 
superior in enhancing the penetration than conventional gel state 
and even liquid state vesicles [8]. Terpenes like cineole, citral and 
limonene are widely used for hydrophilic and lipophilic drugs. 
Dragicevic-Curic et al., 2009preparedsemisolid liposomal 
formulation by mixing with carbomer hydrogel to avoid leaky 
behavior of liposomes on application site [8].Two proposed 
mechanisms of penetration enhancement of terpenes observed are 
permeation as intact vesicles and disruption of intercellular lipid 
lamellae, forming channels[9]. 
Hence the present study deals with improving the solubility of 
curcumin by complexing with CD or HPβCD and then incorporating 
ISSN: 0975-0215 
  
This work is licensed under a Creative Commons Attribution 3.0 License.  
Lakshmi et al. International Journal of Drug Delivery 6 (2) 113-120 [2014] 
 
114 
 
this complex mixture into vesicular carrier invasomes. This 
vesicular carrier is then incorporated into HPMC K4M gel. 
Invasomes are characterized for size, morphology, zeta potential, 
stability. Invasomal gels are investigated for ex vivo permeation 
studies. 
Materials and methods 
Materials 
Curcumin was procured from Sanat Products Limited, New Delhi, 
Soya phosphatidylcholine-70 from Sonic-Biochem extractions, 
limonene, fenchone and nerolidol procured from Alfa aesar, HPMC 
K4M procured from Sigma labs, HPβCD from Otto Kemi and other 
analytical reagents. 
Complexation of Curcumin 
 Curcumin was complexed with β CD and HPβCD according to the 
formula (Table ă 1) by Physical Mixture and Co-precipitation 
method (Zaibunnisa A.H et al., 2011)[5]. 
 
Table 1: Preparation and optimization of curcuminăCD complex. 
Carrier Method 
Drug: 
Carrier 
Percentage 
bound 
HPβCD 
Physical Mixture 
1:1 43% 
1:2 61% 
Co-precipitation 
1:1 65% 
1:2 90% 
β CD 
Physical Mixture 
1:1 24% 
1:2 36% 
Co-precipitation 
1:1 43% 
1:2 54% 
Preparation of invasomes 
Optimized 1:2 co-precipitated complex of Curcumin and HPβCD 
was loaded in to invasomes by mechanical dispersion technique. 
Soya Phosphotidylcholine (1 ă 3% w/v) was added to ethanol and 
vortexed for 5 minutes. Curcumin ă HPβCD complex and different 
terpenes (0.5 ă 1.5%) were added under constant vortexing, this 
mixture was sonicated for 5 minutes. Fine stream of Phosphate 
buffer saline (upto 10%w/v) was added with syringe under constant 
vortexing. It was vortexed for additional 5 minutes to obtain final 
invasomal preparation. 
Entrapment efficiency 
Entrapment efficiency was studied by ultracentrifugation method. 
1ml of invasomal suspension was transferred to Ephendroff tubes, 
centrifuged at 15000 rpm, 4ÀC for 15 min in two cycles to separate 
the unentrapped drug and invasomes. Clear fraction was analyzed 
for free drug at 430 nm spectrophotometrically. Percentage 
entrapped is calculated indirectly from the amount of free drug from 
the formula. 
ܧ݊ݐݎܽ݌݉݁݊ݐ ݂݂݁݅ܿ݅݁݊ܿݕ ሺ%ሻ
ൌ
ݐ݋ݐ݈ܽ ݀ݎݑ݃ െ ݂ݎ݁݁ ݀ݎݑ݃
ݐ݋ݐ݈ܽ ݀ݎݑ݃
 ܺ 100 
Surface morphology 
Surface morphology was studied by placing a drop of preparation 
on a clear glass slide, air dried, coated with gold using sputter 
coater (Polaron E5100, Watford, UK) and visualized under 
Scanning electron microscope (Joel 5400, Japan). 
Ex Vivo permeation studies 
Ex vivo studies were approved by institutional animal ethics 
comittee. Abdominal skin section of male wistar rat was prepared 
and permeation studies were performed using Franz diffusion cell. 
Effective surface area of cell was 2.0 cm2 and has a receptor 
volume of 20ml. Donor compartment was applied with invasomal 
preparation and 20 ml of pH 7.4 phosphate buffer saline 
maintained at 37ÀC was used as receptor medium. Aliquot 
amounts were withdrawn and replaced by fresh media to maintain 
sink condition. Samples were analyzed using UV 
spectrophotometer, steady state transdermal flux (øg/cm2/hr), 
permeability coefficient (cm/hr), enhancement ratio were 
calculated. 
Preparation of Gel 
Aqueous gel of 2% HPMC K4M was prepared by soaking the 
polymer overnight, appropriate amounts of propylene glycol was 
added and mixed until gel was formed. To this gel base optimized 
invasomal suspension was added such that 500 mg of gel contains 
12.5% curcumin. 
Speradability studies 
Spreadability was determined by measuring the spreading 
diameter of 1g of gel between 20X20 cm glass plates for 1 min. 
Mass of upper plate was standardized at 150g. It is calculated by 
using the formula  
ܵ ൌ ܯܮ ܶൗ  
Where S is spreadability, M is weight tied on upper glass plate, L is 
length of glass slide, T is time in sec. 
Extrudability 
Extrudability was carried out by Pfizer hardness tester. 15g of gel 
was filled in aluminium tube and plunger was adjusted to hold the 
tube properly. Pressure of 1 Kg/cm2 was applied for 30 sec and the 
mass of gel extruded was measured. This procedure is repeated at 
three equidistance places of tube. 
Skin irritant studies 
Skin irritant studies were performed on 3 healthy rabbits. 
Unbraided skin was cleaned with rectified spirit, control formulation 
was placed on left dorsal surface and test formulation on right 
dorsal surface. The formulation was removed after 24 hrs and the 
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skin was examined for erythema/edema and scored according to 
primary dermal irritation index classification. 
Stability studies 
Optimized invasomal gel was sealed in 10 ml glass vial and stored 
at refrigeration temperature (4 - 8ÀC) and room temperature for one 
month. Entrapment efficiency, physical appearance was 
determined at regular intervals. 
Results and Discussion 
Characterization of curcumin complex  
Physical mixture, co-precipitation methods using βCD, HPβCD in 
two ratios 1:1 and 1:2 were used for complex preparation. 
Complexes prepared by co-precipitation method showed more 
bonding/ complexing than the physical method. It was found that 
complexation in 1:1 ratio showed 43, 65% bonding by co-
precipitation method with β CD and HPβCD respectively which 
was more than 24, 43% prepared by physical mixing method. 
Similarly with 1:2 ratio it was found to be 54, 90% with β CD and 
HPβCD by co-precipitation method where as only 36, 61% by 
physical mixing method. Complex prepared by co-precipitation 
method in 1:2 ratio with β CD showed complexation of only 54%, 
where as HPβCD showed 90%. Hence co-precipitation method 
showed more bonding than physical method [5] and more bonding 
was observed with 1:2 proportion. 
Solubility of pure curcumin was found to be 2.98X10-11M and 
increased to 1.63X10-8M in HPβCD whereas only 0.21X10-8M with 
βCD. This is accounted because of hydrophilic nature of CD 
derivative HPβCD which enhanced the solubility of poorly water 
soluble curcumin when compared to parent CD [10]. Hence 
curcumin- cyclodextrin complexes prepared by co-precipitation 
method using HPβCD in 1:2 proportion was optimized. 
FTIR spectral studies 
Compatibility studies were performed using Fourier Transform 
Infrared spectrophotometer (FTIR 8400s, Shimadzu, Japan) in the 
range of 4000 ă 400 cm-1 using potassium bromide pellet method. 
Pure curcumin showed absorption peaks at 3504.46 cm-1 
characteristic to hydroxyl (ăOH) group,  peak at 1601 cm-1 
characteristic to C=C of benzene ring, 1506.31 cm-1 characteristic 
to C=O, C=C,  peaks at 1000 ă 1260cm-1 for C-O and are found to 
be near to the absorption bands [11]. The complexed mixture with 
HPβCD also showed peaks in the region of 3503.84, 1601.39, 
1506.73cm-1(figure ă 1). Retention of the peak in the region 1601 
shows that complexes were not formed with carbonyl group of 
curcumin and increase in intensity around the region of C-O ether 
bond shows that complexation was due to this C-O bond of 
curcumin [5].     
 
        Figure 1: Comparision of FTIR spectra. 
 
Figure 2: DSC of curcumin alonend curcumin complex 
DSC studies 
DSC studies were performed and exothermic peaks were observed 
around the region of 170 ă 180ÀC [12] this was because of melting 
of curcumin. The reduced intensity of the peak in complex of 
curcumin with HPβCD indicates complexation of curcumin (figureă 
2). 
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Characterization of invasomes 
Entrapment efficiency 
Invasomes were prepared by mechanical dispersion method. 
Preliminary studies were conducted and 1% soya 
phosphotidylcholine was optimized for further studies as it showed 
maximum entrapment efficiency. Curcumin-HPβCD was taken as 
equivalent to 5mg and incorporated into invasomes with different 
terpenes limonene, fenchone, nerolidol at 3 levels 0.5, 1, 1.5% 
individually and 4% of ethanol was added to all the 
formulations(table ă 2). Entrapment efficiency of each formulation 
was calculated and it was found to be maximum inCHL1- 
93.5μ0.08%, 88.4μ0.11 in CHF1, 87.4μ0.12 in CHL2, 76.8μ0.07 in 
CHF2 and least in CHN3 - 58.4μ0.06. Entrapment efficiency with 
different terpenes was found in the order limonene > fenchone 
>nerolidol. Limonene showed highest entrapment efficiency which 
is attributed due to the presence of hydrocarbon group. 
Surface morphology 
Characterization of invasomes 
Vesicular size 
Vesicle size was determined using Microtel X100 Leeds & Northrup 
particle size analyzer, UK and it was observed to be 134.7nm and 
poly dispersity index was < 0.2 for CHL1. 
Zeta potential 
 Zeta potential was measured at Malvern Instruments Ltd using 
Zeta sizer and was found to be -33.7mv for CHL1. Negative charge 
may be imparted due to the presence of ethanol [7,12]. 
In vitro studies 
In vitro diffusion studies were carried out using dialysis membrane 
to evaluate release from invasomes. Release profile for 24 hrs 
study is shown in figure 3.Three terpene formulations CHL1, CHL2, 
CHF2 showed good release rate of 22.31μ3.0, 20.89μ2.8, 
15.25μ1.9 
respectively. In previous studies 1% terpene formulations showed 
better release [13] but the results show that 0.5% limonene showed 
good release than 1% formulation this may be attributed to 
presence of ethanol in the formulations. These three formulations 
were selected for ex vivo studies. Although CHF1 showed good 
entrapment efficiency of 88.4 μ 0.11 because of its release rate 
compared to CHF2 it was not selected for further studies. 
Ex vivo skin permeation studies 
Ex vivo studies were approved by IAEC. Permeation studies were 
conducted using excised male wistar rat abdominal skin and were 
performed usingFranz diffusion cell. Cumulative drug permeated 
was found to be 70.32μ1.98 for CHL1, 60.58μ2.61 for CHL2, 
51.8μ3.02 for CHF2 which was found to be more than control 
22.89μ2.08. D. D. Verma et al., observed increase in permeation 
with increase in ethanol [14],many literatures discusses the 
increase in permeation with terpene loaded vesicles when 
compared with liposome vesicles. Increased permeation in 
formulation with terpenes than conventional liposomes (control) 
may be attributed to synergistic effect of ethanol and terpenes as 
formulation CE prepared without terpenes also showed increase in 
permeation of 40.32μ2.76 [7](table ă 2).  
 
 
 
Figure 3: Release profile of prepared invasomal formulations. 
 
 
Penetration parameters like steady state transdermal flux and 
permeability coefficient were calculated. Control formulation 
showed flux of 0.41μ0.14 øg/cm2/hr, maximum flux was observed 
with CHL1 3.34 μ 0.08 and increased flux of 3.02 μ 0.07 with CHL2 
and 2.28 μ 0.16 with CHF2. 
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JSS ă steady state flux, dM ă amount of drug permeated, S ăunit of 
cross section, t ă time, CV ă total concentration in the donar 
compartment, Kpă permeability coefficient. 
Permeability coefficient was found to be 5.35μ0.03 X10-3 with 
CHL1, 4.83μ0.07X10-3, 3.66μ0.06X10-3 with CHL2 and CHF2, 
where as only 0.32μ0.04X10-3 with control and 0.98μ0.09 CE (with 
out terpenes). 
 
Table 2: Formulation and Evaluation results of Invasome preparations 
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Control - - - ND ND 22.89μ 2.08 0.41μ 0.14 0.32μ 0.04 1 3.6 μ 0.12
CE - - - ND ND 40.32μ2.76 1.73μ0.19 0.98μ0.09 4.2 2.4μ0.5
CHL1 0.5 - - 93.5 μ 0.08 22.31 μ 3.0 70.32μ 1.98 3.34μ 0.08 5.35μ 0.03 8.11 1 μ 0.2
CHL2 1 - - 87.4 μ 0.12 20.89 μ 2.8 60.58μ 2.64 3.02μ 0.07 4.83μ 0.07 7.33 1.2μ 0.1
CHL3 1.5 - - 82.2 μ 0.06 19.34 μ 2.4 ND ND ND ND ND 
CHF1 - 0.5 - 88.4 μ 0.11 14.26 μ 1.0 ND ND ND ND ND 
CHF2 - 1 - 76.8 μ 0.07 15.25 μ 1.9 51.8μ 3.02 2.28μ 0.16 3.66μ 0.06 5.55 1.9μ 0.6
CHF3 - 1.5 - 68.7 μ 0.13 10.33 μ 2.0 ND ND ND ND ND 
CHN1 - - 0.5 76.5 μ 0.08 12.98 μ 2.8 ND ND ND ND ND 
CHN2 - - 1 64.8 μ 0.12 14.86 μ 2.7 ND ND ND ND ND 
CHN3 - - 1.5 58.4 μ 0.06 8.79 μ 2.7 ND ND ND ND ND 
CNT G - - - - - 7.98μ 1.86 0.28 μ0.03 0.45μ0.02 1 4.2μ0.2 
CHL1G - - - - - 52.8μ 2.32 2.21 μ0.27 3.53μ0.08 7.78 2.5 μ0.1 
CHL2G - - - - - 42.32μ 2.52 1.77 μ0.08 2.84μ0.04 6.25 2μ0.05 
Curcumin ă Hydroxy propyl β cyclodextrin complex ă 5 mg (5% w/v), Soya lecithin ă 1%, Ethanol ă 4% in all formulations except control, L-limonene, F- 
Fenchone, N- nerolidol, ND- not determined, SSTF - Steady state transdermal flux. 
 
Enhancement ratio was calculated by comparing the formulations 
CHL1, CHL2, CHF2 with Control. CHL1 was found to enhance by 
8.11 time and only 7.33, 5.55 times with CHL2, CHF2 respectively. 
T. Subongkot et al. also reported enhancement of 6.8 ă 8 folds in 
ultradeformable vesicles compared to liposomes [9]. Lag time 
decreased with the use of terpenes when compared with control 
from 3.6μ0.12 for control to 1μ0.2, 1.2μ0.1, 1.9μ0.6 for CHL1, 
CHL2, CHF2 respectively owing to increased permeation effect of 
terpenes. Permeation enhancement of present study are in 
controversy with other authors but are according to the results of 
work of A. F. El-kattan et al., 2001 [16] where limonene showed 
high entrapment with lipophilic drugs. The increase in the 
permeation observed with limonene may be due to its lipophilicity 
and low boiling point [17] and lipophilic nature of curcumin. 
Organoleptic characterization of gel 
The optimized invasomal suspension CHL1, CHL2 was 
incorporated in to 2% HPMC K4M which was optimized by 
preliminary trials. Prepared gel was inspected under black and 
white background and was found very clear and without any 
aggregates.  
The pH of the gel was determined using digital pH meter LI 127 
Elico. 0.5g of gel was dispersed in 100 ml of pH 7.4 Phosphate 
buffer and checked for its pH. It was found to be 6.9, 7.0 for CHL1, 
CHL2 respectively. 
Spreadability and Extrudability were performed as mentioned 
earlier and spreadability was found to be 27.07cm, 24.96cm for 
CHL1, CHL2 respectively, and extrudability was found to be 
excellent. 
Viscosity was measured using LV DV-II+Pro Brookfield 
programmable viscometer with spindle 64, and was found to be 
3982μ2cp, 3896μ1cp with CHL1, CHL2 respectively. 
Lakshmi et al. International Journal of Drug Delivery 6 (2) 113-120 [2014] 
 
118 
 
Ex vivo studies of gel 
Ex vivo studies were conducted for prepared gels and were 
compared with control. Release profile is shown in figure 4. 
Cumulative drug permeated was found to be 52.8μ2.32, 
42.32μ2.52øg/cm2for CHL1G, CHL2G but with control it was just 
7.98μ1.86øg/cm2. Steady state transdermal flux was found to be 
2.21μ0.27, 1.77μ0.08øg/cm2/hr for CHL1G, CHL2G respectively 
and 0.28μ0.03 øg/cm2/hr for control. Permeability coefficient was 
3.53μ0.08X10-3, 2.84μ0.04X10-3 for CHL1G, CHL2G and 
0.45μ0.02X10-3 cm/hr. Enhancement ratio was found to be 7.78, 
6.25 times for CHL1G,CHL2G. Lag time decreased from 4.2μ0.2 
for control to 2.5μ0.11, 2μ0.05 hrs for CHL1G, CHL2G 
respectively. Drug permeation, flux, enhancement ratio and lag 
time was observed to be high for gel preparation with CHL1G  
 
Figure 4: Ex vivo permeation studies 
 
Statistical analysis 
The results obtained were analyzed statistically using one way 
ANOVA (TukeyÊs multiple comparison test) and is depicted in (table 
3).Results of control and CHL1 were significant (p<0.001) in SSTF, 
Q24, permeability coefficient, enhancement ratio and lag time, 
CHL1 and CHL2 were significant (p<0.001) in permeability 
coefficient and enhancement ratio but Q24, SSTF and lag time 
were not significant (p>0.05). CHL1 and CHF2 were significant 
(p<0.01) in permeability and enhancement, Q24 and SSTF but lag 
time was not significant (p.0.05). Comparing CHL2 with control 
showed significance of p<0.001 for SSTF, Q24, permeability 
coefficient, enhancement ratio, lag time. CHL2 and CHF2 are 
significant in permeability, enhancement (p<0.001), Q24 and SSTF 
were not significant. Comparing CHF2 with control Q24, 
permeability coefficient, enhancement ratio showed significance of 
p<0.01, SSTF with significance of P<0.005 and significance of 
p<0.01 in lag time. 
SSTF, Q24, permeability coefficient, enhancement ratio and lag 
time were observed to be significant to p<0.001 in CHL1G and 
CHL2G with control but lag time was not significant in CHL2G. 
SSTF, Q24, permeability coefficient, enhancement ratio were 
significant but lag time was not significant (p>0.05) when 
comparing CHL1G, CHL2G. 
From this analysis it is observed that terpenes shows significant 
effect on permeability coefficient and flux was influenced by 
permeability enhancer. Least lag time was observed with CHL2G 
 
Table 3: Statistical analysis by ANOVA (Tukeys multiple comparison test) 
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n = 2; *** (p<0.001); ** (p<0.01); * (p<0.005); NS ă non significant (p>0.05) 
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 Table 4: release kinetics of prepared invasomes and gel. 
Formulations 
Zero order First order Higuchi Peppas
Release mechanism 
r2 r2 r2 r2 n
In
va
so
m
es
 CHL1 0.990 0.9068 0.952 0.982 0.434 Fickian diffusion 
CHL2 0.996 0.7341 0.936 0.923 0.471 Fickian diffusion 
CHF2 0.995 0.8202 0.939 0.969 0.472 Fickian diffusion 
G
e
l 
CHL1G 0.992 0.9078 0.962 0.982 0.454 Fickian diffusion
CHL2G 0.986 0.7641 0.926 0.943 0.431 Fickian diffusion
Release kinetics of optimized 0 order kinetics, fickian n<0.5 
 
Release kinetics 
Release kinetics was observed by fitting the data in to Zero order, 
First order, HiguchiÊs, Korsemeyer peppas equations and was 
found to follow zero order release with Fickian diffusion 
mechanism.Table-4  
Skin irritation studies were performed on depilated rabbit and was 
assessed and scored according to primary dermal irritation index 
classification. Gel formulation CHL1G was applied on to depilated 
skin and was confirmed that there was no sign of erythema or 
edema. 
Stability studies 
Stability studies of optimized formulation was carried out by sealing 
the formulation in 10 ml glass vial and refrigerated at 4 - 8ÀC and at 
room temperature for 1 month. Drug content was determined and 
there was a decrease of only 10 % of entrapped drug after 1 month 
when stored at refrigeration. But when stored at room temperature 
the loss was upto 50%. Hence curcumin loaded invasomes are 
stored at 4 - 8ÀC as aggravated temperatures causes leaking by 
transition of lipid bilayer or chemical degradation of lipids. 
 
Conclusion 
Because of its poor solubility, its instability in alkaline pH curcumin 
is formulated as transdermal formulation. Curcumin was 
complexed with βCD and HPβCD. Improved solubility and stability 
was observed with HPβCD prepared by co-precipitation method 
than physical mixture method. Optimized complex ie., 1:2 
proportion complex is incorporated into invasomes with limonene, 
fenchone, nerolidol as terpenes which acted as phospholipid 
membrane flexibilizers, penetration enhancers. 1% soya 
phosphotidylcholine, 0.5% limonene was optimized which showed 
Q24 of 70.32 øg/cm2, SSTF of 3.34 øg/cm2/hr-1, permeability 
coefficient of 5.35 cm/hr, and decreased lag time of 1 hr. 
formulation CHL1 was found to be better in all characteristics and 
was incorporated into 2% HPMC K4M gel formulation. Further in 
vivo studies are to be carried out to assess the pharmacokinetics of 
curcumin invasomal formulations. 
Abbreviations 
HPMC- Hydroxy propyl methyl cellulose 
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